Scaffolding actions of membrane-associated progesterone receptors

Steroids

Volumn 74, Issue 7, 2009, Pages 568-572

  Hagan, Christy R ^a   Faivre, Emily J ^a   Lange, Carol A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

c Src; CD domain; MEK1; Progesterone receptor; Rapid kinase activation; Scaffold

Indexed keywords

ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PROGESTERONE; PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; PROGESTERONE RECEPTOR C; PROTEIN KINASE; SCAFFOLD PROTEIN; STEROID RECEPTOR; UNCLASSIFIED DRUG;

BREAST DEVELOPMENT; CELL MEMBRANE; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; CYTOPLASM; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; NONHUMAN; ONCOGENE SRC; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; REVIEW;

ANIMALS; CELL MEMBRANE; HUMANS; MAP KINASE SIGNALING SYSTEM; NUCLEAR MATRIX-ASSOCIATED PROTEINS; RECEPTORS, PROGESTERONE; SIGNAL TRANSDUCTION;

EID: 63749084159     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2008.12.004     Document Type: Review

References (37)

1. Kastner P., Krust A., Turcotte B., Stropp U., Tora L., Gronemeyer H., et al. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 9 (1990) 1603-1614
2. Wei L.L., Norris B.M., and Baker C.J. An N-terminally truncated third progesterone receptor protein, PR(C), forms heterodimers with PR(B) but interferes in PR(B)-DNA binding. J Steroid Biochem Mol Biol 62 4 (1997) 287-297
3. Condon J.C., Hardy D.B., Kovaric K., and Mendelson C.R. Up-regulation of the progesterone receptor (PR)-C isoform in laboring myometrium by activation of nuclear factor-kappaB may contribute to the onset of labor through inhibition of PR function. Mol Endocrinol 20 4 (2006) 764-775
4. Conneely O.M., Mulac-Jericevic B., Lydon J.P., De F.J., and Mayo. Reproductive functions of the progesterone receptor isoforms: lessons from knock-out mice. Mol Cell Endocrinol 179 1/2 (2001) 97-103
5. Lydon J.P., DeMayo F.J., Funk C.R., Mani S.K., Hughes A.R., Montgomery C.A., et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 9 (1995) 2266-2278
6. Mulac-Jericevic B., Lydon J.P., DeMayo F.J., and Conneely O.M. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc Natl Acad Sci USA 100 17 (2003) 9744-9749
7. Shyamala G., Yang X., Silberstein G., Barcellos-Hoff M.H., and Dale E. Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. Proc Natl Acad Sci USA 95 2 (1998) 696-701
8. Richer J.K., Jacobsen B.M., Manning N.G., Abel M.G., Wolf D.M., and Horwitz K.B. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem 277 7 (2002) 5209-5218
9. Daniel A.R., Faivre E.J., and Lange C.A. Phosphorylation-dependent antagonism of sumoylation de-represses progesterone receptor action in breast cancer cells. Mol Endocrinol (2007)
10. Lange C.A., Shen T., and Horwitz K.B. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc Natl Acad Sci USA 97 3 (2000) 1032-1037
11. Rao K.V., Peralta W.D., Greene G.L., and Fox C.F. Cellular progesterone receptor phosphorylation in response to ligands activating protein kinases. Biochem Biophys Res Commun 146 3 (1987) 1357-1365
12. Knotts T.A., Orkiszewski R.S., Cook R.G., Edwards D.P., and Weigel N.L. Identification of a phosphorylation site in the hinge region of the human progesterone receptor and additional amino-terminal phosphorylation sites. J Biol Chem 276 11 (2001) 8475-8483
13. Takimoto G.S., Hovland A.R., Tasset D.M., Melville M.Y., Tung L., and Horwitz K.B. Role of phosphorylation on DNA binding and transcriptional functions of human progesterone receptors. J Biol Chem 271 23 (1996) 13308-13316
14. Weigel N.L. Steroid hormone receptors and their regulation by phosphorylation. Biochem J 319 Pt 3 (1996) 657-667
15. Zhang Y., Beck C.A., Poletti A., Clement JPt, Prendergast P., Yip T.T., et al. Phosphorylation of human progesterone receptor by cyclin-dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo. Mol Endocrinol 11 6 (1997) 823-832
16. Zhang Y., Beck C.A., Poletti A., Edwards D.P., and Weigel N.L. Identification of phosphorylation sites unique to the B form of human progesterone receptor. In vitro phosphorylation by casein kinase II. J Biol Chem 269 49 (1994) 31034-31040
17. Zhang Y., Beck C.A., Poletti A., Edwards D.P., and Weigel N.L. Identification of a group of Ser-Pro motif hormone-inducible phosphorylation sites in the human progesterone receptor. Mol Endocrinol 9 8 (1995) 1029-1040
18. Qiu M., Olsen A., Faivre E., Horwitz K.B., and Lange C.A. Mitogen-activated protein kinase regulates nuclear association of human progesterone receptors. Mol Endocrinol 17 4 (2003) 628-642
19. Pierson-Mullany L.K., and Lange C.A. Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase2. Mol Cell Biol 24 24 (2004)
20. Shen T., Horwitz K.B., and Lange C.A. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294. Mol Cell Biol 21 18 (2001) 6122-6131
21. Narayanan R., Adigun A.A., Edwards D.P., and Weigel N.L. Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator. Mol Cell Biol 25 1 (2005) 264-277
22. Weigel N.L., Bai W., Zhang Y., Beck C.A., Edwards D.P., and Poletti A. Phosphorylation and progesterone receptor function. J Steroid Biochem Mol Biol 53 1-6 (1995) 509-514
23. Boonyaratanakornkit V., Scott M.P., Ribon V., Sherman L., Anderson S.M., Maller J.L., et al. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell 8 2 (2001) 269-280
24. Migliaccio A., Piccolo D., Castoria G., Di Domenico M., Bilancio A., Lombardi M., et al. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J 17 7 (1998) 2008-2018
25. Ballare C., Uhrig M., Bechtold T., Sancho E., Di Domenico M., Migliaccio A., et al. Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells. Mol Cell Biol 23 6 (2003) 1994-2008
26. Boonyaratanakornkit V., McGowan E., Sherman L., Mancini M.A., Cheskis B.J., and Edwards D.P. The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle. Mol Endocrinol 21 2 (2007) 359-375
27. Wasielewski M., Elstrodt F., Klijn J.G., Berns E.M., and Schutte M. Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines. Breast Cancer Res Treat 99 1 (2006) 97-101
28. Murphy L.O., MacKeigan J.P., and Blenis J. A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration. Mol Cell Biol 24 1 (2004) 144-153
29. Murphy L.O., Smith S., Chen R.H., Fingar D.C., and Blenis J. Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol 4 8 (2002) 556-564
30. Rubinfeld H., Hanoch T., and Seger R. Identification of a cytoplasmic-retention sequence in ERK2. J Biol Chem 274 43 (1999) 30349-30352
31. Tanoue T., Adachi M., Moriguchi T., and Nishida E. A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat Cell Biol 2 2 (2000) 110-116
32. Ranganathan A., Pearson G.W., Chrestensen C.A., Sturgill T.W., and Cobb M.H. The MAP kinase ERK5 binds to and phosphorylates p90 RSK. Arch Biochem Biophys 449 1/2 (2006) 8-16
33. Burgermeister E., Chuderland D., Hanoch T., Meyer M., Liscovitch M., and Seger R. Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma. Mol Cell Biol 27 3 (2007) 803-817
34. Faivre E.J., Daniel A.R., Hillard C.J., and Lange C.A. Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors. Mol Endocrinol 22 4 (2008) 823-837
35. Tanoue T., and Nishida E. Docking interactions in the mitogen-activated protein kinase cascades. Pharmacol Ther 93 2/3 (2002) 193-202
36. Arnold S.F., Obourn J.D., Jaffe H., and Notides A.C. Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by src family tyrosine kinases in vitro. Mol Endocrinol 9 1 (1995) 24-33
37. Arnold S.F., Vorojeikina D.P., and Notides A.C. Phosphorylation of tyrosine 537 on the human estrogen receptor is required for binding to an estrogen response element. J Biol Chem 270 50 (1995) 30205-30212